AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) posted a loss of 78 cents per share during the third quarter of 2011, narrower than the Zacks Consensus Estimate of a loss of $1.00 per share as well as the year-ago loss of 81 cents per share. The narrower loss was due to lower-than-expected operating expenses. AMAG also announced a broad restructuring plan to reduce operating expenses and the departure of its CEO Dr. Pereira. Management is evaluating all strategic alternatives for the company, including a … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards